The "C" of viral hepatitis in children.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Seminars in liver disease (Print)

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2007-985074PMID 17682976
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study.

  2007cited by this paper
• Hepatitis C virus p7 protein is localized in the endoplasmic reticulum when it is encoded by a replication-competent genome.

  2007cited by this paper
• Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period.

  2007cited by this paper
• Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

  2007cited by this paper
• A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.

  2006cited by this paper
• The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period.

  2006cited by this paper
• Hepatitis C in Children: A Quaternary Referral Center Perspective

  2006cited by this paper
• Accuracy of HCV‐RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection

  2006cited by this paper
• A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients.

  2006cited by this paper
• Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference

  2006cited by this paper
• Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively.

  2006cited by this paper
• Safety, Efficacy and Pharmacokinetics of Peginterferon &agr;2a (40 kd) in Children With Chronic Hepatitis C

  2006cited by this paper
• Treating HCV with ribavirin analogues and ribavirin-like molecules.

  2006cited by this paper
• Compensatory Mutations in E1, p7, NS2, and NS3 Enhance Yields of Cell Culture-Infectious Intergenotypic Chimeric Hepatitis C Virus

  2006cited by this paper
• Hepatitis C virus entry: potential receptors and their biological functions.

  2006cited by this paper
• The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others.

  2005cited by this paper
• Mechanism of action of interferon and ribavirin in treatment of hepatitis C

  2005cited by this paper
• The management of HCV infected pregnant women and their children European paediatric HCV network.

  2005cited by this paper
• Unravelling hepatitis C virus replication from genome to function

  2005cited by this paper
• Evasion of intracellular host defence by hepatitis C virus

  2005cited by this paper
• Global epidemiology of hepatitis C virus infection.

  2005cited by this paper
• Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy.

  2005cited by this paper
• Chronic hepatitis C in childhood: an 18-year experience.

  2005cited by this paper
• Three broad modalities in the natural history of vertically acquired hepatitis C virus infection.

  2005cited by this paper
• Hepatitis C Virus NS2/3 Processing Is Required for NS3 Stability and Viral RNA Replication*

  2005cited by this paper
• Peginterferon alfa‐2b plus ribavirin treatment in children and adolescents with chronic hepatitis C

  2005cited by this paper
• Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women.

  2005cited by this paper
• Quantitative Analysis of the Hepatitis C Virus Replication Complex

  2005cited by this paper
• Interferon alfa‐2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics

  2005cited by this paper
• Evolution in the hypervariable region of the hepatitis C virus in two infants infected by mother‐to‐infant transmission

  2005cited by this paper
• A significant sex--but not elective cesarean section--effect on mother-to-child transmission of hepatitis C virus infection.

  2005cited by this paper
• A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.

  2005cited by this paper
• Differing Patterns of Liver Disease Progression and Hepatitis C Virus (HCV) Quasispecies Evolution in Children Vertically Coinfected with HCV and Human Immunodeficiency Virus Type 1

  2004cited by this paper
• Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

  2004cited by this paper
• Long‐term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth

  2004cited by this paper
• The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences

  2003cited by this paper
• Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

  2003cited by this paper
• Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons

  2003cited by this paper
• Vertical Transmission of the Hepatitis C Virus to Infants of Anti-Human Immunodeficiency Virus-Negative Mothers: Molecular Evolution of Hypervariable Region 1 in Prenatal and Perinatal or Postnatal Infections

  2003cited by this paper
• Early virologic response to treatment with peginterferon alfa‐2b plus ribavirin in patients with chronic hepatitis C

  2003cited by this paper
• Clinical features and progression of perinatally acquired hepatitis C virus infection

  2003cited by this paper
• Developmental toxicity of ribavirin/IFalpha combination therapy: is the label more dangerous than the drugs?

  2003cited by this paper
• Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children.

  2003cited by this paper
• Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis.

  2003cited by this paper
• Prospective study of mother‐to‐infant transmission of hepatitis C virus: a 10‐year survey (1990–2000)

  2003cited by this paper
• Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood.

  2003cited by this paper
• An Analysis of Published Trials of Interferon Monotherapy in Children With Chronic Hepatitis C

  2002cited by this paper
• Interaction between hepatitis C virus proteins and host cell factors.

  2002cited by this paper
• Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

  2002cited by this paper
• Recombinant alfa‐interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C

  2002cited by this paper
• Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs.

  2002cited by this paper
• Hepatitis C Virus IRES RNA-Induced Changes in the Conformation of the 40S Ribosomal Subunit

  2001cited by this paper
• Functional classification of interferon‐stimulated genes identified using microarrays

  2001cited by this paper
• Prospective study of mother-to-infant transmission of hepatitis C virus.

  2001cited by this paper
• Viruses and interferons.

  2001cited by this paper
• Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection.

  2000cited by this paper
• Interferon-α and Ribavirin in Treating Children and Young Adults With Chronic Hepatitis C After Malignancy

  2000cited by this paper
• Estimating future hepatitis C morbidity, mortality, and costs in the United States.

  2000cited by this paper
• Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody.

  2000cited by this paper
• Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission.

  2000cited by this paper
• Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission.

  2000cited by this paper
• Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women

  2000cited by this paper
• The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

  1999cited by this paper
• A Prospective Study on Mother-to-Infant Transmission of Hepatitis C Virus

  1999cited by this paper
• Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1

  1998cited by this paper
• Chronic hepatitis C in children: A clinical and immunohistochemical comparative study with adult patients

  1998cited by this paper
• Vertical transmission of hepatitis C virus infection: usefulness of viremia detection in HIV-seronegative hepatitis C virus-seropositive mothers.

  1998cited by this paper
• Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy.

  1998cited by this paper
• Interferon-alpha treatment of chronic hepatitis C virus infection in children.

  1998cited by this paper
• Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization

  1998cited by this paper
• Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.

  1998cited by this paper
• Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

  1998cited by this paper
• Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

  1998cited by this paper
• Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers.

  1998cited by this paper
• Critical role of Val/Gly86 HLA-DRB dimorphism in the neonatal resistance or susceptibility to maternal hepatitis C virus infection.

  1997cited by this paper
• Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus

  1997cited by this paper
• Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy.

  1997cited by this paper
• Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group.

  1996cited by this paper
• Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C

  1996cited by this paper
• Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population

  1995cited by this paper
• Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy.

  1995cited by this paper
• Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers.

  1995cited by this paper
• Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion.

  1994cited by this paper
• Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites

  1993cited by this paper
• Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

  1992cited by this paper
• The declining risk of post-transfusion hepatitis C virus infection.

  1992cited by this paper
• Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.

  1991cited by this paper

• Treatment of hepatitis C virus chronic infection in children: is there a cure in sight or are we far away from the goal?

  2019cites this paper
• [Tratamiento de infección crónica por virus de hepatitis C en niños, ¿perspectiva hacia la curación o lejos de la meta?]

  2018cites this paper
• [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection].

  2018cites this paper
• Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediat

  2013cites this paper
• Non Invasive Assessment of Hepatic Fibrosis and Necro-inflammatory Activity in Pediatric Patients with Chronic Hepatitis C Virus Infection: A Pilot Study of the Role of FibroTest and ActiTest in Children

  2012cites this paper
• Chapter 18 – Neonatal Cholestasis

  2012cites this paper
• Etiology and Management of Hemorrhagic Complications of Portal Hypertension in Children

  2012cites this paper
• Treatment of hepatitis C virus infection in adults and children: Updated Swedish consensus recommendations

  2012cites this paper
• BISTABILITY AND LONG-TERM CURE IN A WITHIN-HOST MODEL OF HEPATITIS C

  2011cites this paper
• A Guide for Evaluation and Treatment of Hepatitis C in Adults Coinfected with HIV

  2011cites this paper
• Epidemiology and Natural History of Hepatitis C in Children

  2010cites this paper
• Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest

  2010cites this paper
• Interferon induction regimen for chronic hepatitis C genotype 4 in Egyptian children

  2010cites this paper
• Hepatitis C en población pediátrica: panorama actual Hepatitis C in children: Present overview

  2009cites this paper
• Treatment of hepatitis C virus infection: Updated Swedish Consensus recommendations

  2009cites this paper
• Hepatitis C en población pediátrica: panorama actual

  2009cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and

  2009cites this paper
• A not so uncommon cause of abdominal pain

  2008cites this paper
• Chronic viral hepatitis in children: any role for the pathologist?

  2008cites this paper
• The “C” of Viral Hepatitis in Children

  2007cites this paper